Advanced BioMedical Technologies, Inc. — Net Income by Fiscal Year
18 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8a567992-332f-4de7-ad75-18d1cb91b385/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2020 | $-672.0k | 2019-11-01 – 2020-10-31 | evidence 0001493152-21-002055 |
| FY 2019 | $-948.8k | 2018-11-01 – 2019-10-31 | evidence 0001493152-20-004401 |
| FY 2018 | $-953.3k | 2017-11-01 – 2018-10-31 | evidence 0001493152-19-001841 |
| FY 2017 | $-691.6k | 2016-11-01 – 2017-10-31 | evidence 0001493152-18-001918 |
| FY 2016 | $-724.7k | 2015-11-01 – 2016-10-31 | evidence 0001387131-17-000831 |
| FY 2015 | $-862.9k | 2014-11-01 – 2015-10-31 | evidence 0001387131-16-004238 |
| FY 2014 | $-827.8k | 2013-11-01 – 2014-10-31 | evidence 0001354488-15-000348 |
| FY 2013 | $-5.0M | 2002-09-25 – 2014-04-30 | evidence 0001354488-14-003388 |
| FY 2012 | $-4.0M | 2002-09-25 – 2013-04-30 | evidence 0001354488-13-003480 |
| FY 2011 | $-3.3M | 2002-09-25 – 2012-04-30 | evidence 0001387131-12-001958 |
| FY 2010 | $-816.8k | 2009-11-01 – 2010-10-31 | evidence 0001387131-11-002099 |
| FY 2009 | $-558.4k | 2008-11-01 – 2009-10-31 | evidence 0001354488-13-000594 |
| FY 2008 | $-227.0k | 2008-01-01 – 2008-10-31 | evidence 0001354488-13-000594 |
| FY 2007 | $-196.9k | 2007-01-01 – 2007-12-31 | evidence 0001387131-11-002099 |
| FY 2006 | $-191.0k | 2006-01-01 – 2006-12-31 | evidence 0001387131-11-002099 |
| FY 2005 | $-511.2k | 2005-01-01 – 2005-12-31 | evidence 0001387131-11-002099 |
| FY 2004 | $-94.2k | 2004-01-01 – 2004-12-31 | evidence 0001387131-11-002099 |
| FY 2003 | $-57.6k | 2003-01-01 – 2003-12-31 | evidence 0001354488-13-000594 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Advanced BioMedical Technologies, Inc. — all facts · Operating Income